Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
David Weinberg: Only NCI has the capacity to answer public health question on managing pancreatic cysts
Conversation with The Cancer LetterFree

David Weinberg: Only NCI has the capacity to answer public health question on managing pancreatic cysts

October 08, 2021
Vol.47 No.37
By Paul Goldberg
Peter O’Dwyer and Mitch Schnall on the challenges of running screening and prevention trials
Conversation with The Cancer LetterFree

Peter O’Dwyer and Mitch Schnall on the challenges of running screening and prevention trials

October 08, 2021
Vol.47 No.37
By Paul Goldberg
U.S. cancer patients gained 14 million life-years since 1980 because of NCI-funded trials

U.S. cancer patients gained 14 million life-years since 1980 because of NCI-funded trials

October 01, 2021
Vol.47 No.36
By Matthew Bin Han Ong
Biden administration blocks Trump’s last-minute appointees from getting on NCAB

Biden administration blocks Trump’s last-minute appointees from getting on NCAB

September 24, 2021
Vol.47 No.35
By Alice Tracey and Paul Goldberg
John Ellerton receives 2021 NCORP Harry Hynes Award

John Ellerton receives 2021 NCORP Harry Hynes Award

September 17, 2021
Vol.47 No.34
By Paul Goldberg
NCI requests $7.8B for FY2023 to increase R01 paylines to 13th percentile
NCI

NCI requests $7.8B for FY2023 to increase R01 paylines to 13th percentile

September 10, 2021
Vol.47 No.33
By Matthew Bin Han Ong
As his center wins comprehensive (again), Carlos Arteaga tells us how NCI’s standards have evolved
Conversation with The Cancer Letter

As his center wins comprehensive (again), Carlos Arteaga tells us how NCI’s standards have evolved

September 10, 2021
Vol.47 No.33
By Paul Goldberg
Congressional letter based on Grothey case demands answers on NIH policies on sexual misconduct by advisors
Capitol HillFree

Congressional letter based on Grothey case demands answers on NIH policies on sexual misconduct by advisors

September 03, 2021
Vol.47 No.32
By Paul Goldberg and Matthew Bin Han Ong
Cancer Crusade tells the gripping story of the National Cancer Act
Cancer History ProjectFree

Cancer Crusade tells the gripping story of the National Cancer Act

August 06, 2021
Vol.47 No.31
By Otis W. Brawley and Paul Goldberg
The history—and future—of oncology, according to directors of the first three NCI-designated Comprehensive Cancer Centers
Cancer History ProjectFree

The history—and future—of oncology, according to directors of the first three NCI-designated Comprehensive Cancer Centers
“There couldn’t be a better time to be in oncology”

August 06, 2021
Vol.47 No.31
By Katie Goldberg and Alexandria Carolan

Posts navigation

Previous1…34353637Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
  • Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
  • One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
  • As more people are surviving cancer, we must continue funding bold science
  • GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
    Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account